Latest filings (excl ownership)
15-12G
Securities registration termination
24 Jul 23
EFFECT
Notice of effectiveness
24 Jul 23
EFFECT
Notice of effectiveness
24 Jul 23
EFFECT
Notice of effectiveness
24 Jul 23
POS AM
Prospectus update (post-effective amendment)
20 Jul 23
POS AM
Prospectus update (post-effective amendment)
20 Jul 23
POS AM
Prospectus update (post-effective amendment)
20 Jul 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jul 23
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Jul 23
6-K
Current report (foreign)
17 Jul 23
25
Voluntary exchange delisting
10 Jul 23
SC 14D9/A
Tender offer solicitation (amended)
29 Jun 23
6-K
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
29 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
29 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
26 Jun 23
SC 14D9/A
Tender offer solicitation (amended)
26 Jun 23
6-K
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
26 Jun 23
SC 14D9/A
Tender offer solicitation (amended)
20 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
20 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
16 Jun 23
SC 14D9/A
Tender offer solicitation (amended)
16 Jun 23
6-K
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
16 Jun 23
6-K
Current report (foreign)
5 Jun 23
6-K
Current report (foreign)
2 Jun 23
SC 14D9
Tender offer solicitation
31 May 23
SC TO-T
Third party tender offer statement
31 May 23
SC14D9C
Written communication relating to third party tender offer
25 May 23
SC TO-C
Information about tender offer
23 May 23
SC14D9C
Written communication relating to third party tender offer
22 May 23
SC TO-C
Information about tender offer
22 May 23
SC TO-C
Information about tender offer
22 May 23
SC14D9C
Written communication relating to third party tender offer
22 May 23
6-K
Current report (foreign)
22 May 23
6-K
Current report (foreign)
10 May 23
20-F
2022 FY
Annual report (foreign)
19 Apr 23
6-K
VectivBio Reports Full Year 2022 Financial Results and Provides Business Update
19 Apr 23
6-K
Announcement of the Annual General Meeting of
6 Apr 23
EFFECT
Notice of effectiveness
27 Feb 23
CORRESP
Correspondence with SEC
22 Feb 23
UPLOAD
Letter from SEC
1 Feb 23
Latest ownership filings
SC 13G/A
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 24
SC 13D
IRONWOOD PHARMACEUTICALS INC
7 Jul 23
SC 13G
Beryl Capital Management LLC
5 Jun 23
SC 13G/A
Novo Holdings A/S
26 May 23
SC 13D
ORBIMED ADVISORS LLC
24 May 23
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 23
SC 13G/A
Cormorant Asset Management, LP
14 Feb 23
SC 13G/A
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13G/A
CHI Advisors LLC
13 Feb 23
SC 13G/A
Novo Holdings A/S
2 Feb 23
SC 13D/A
Forbion Growth Opportunities Fund II Cooperatief U.A.
13 Dec 22
SC 13D/A
Bpifrance Participations SA
20 Oct 22
SC 13D
Forbion Growth Opportunities Fund II Cooperatief U.A.
7 Jul 22
SC 13D/A
Bpifrance Participations SA
28 Jun 22
SC 13G
Cormorant Asset Management, LP
17 Jun 22
SC 13G
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
CHI Advisors LLC
11 Feb 22
SC 13G
ORBIMED ADVISORS LLC
11 Feb 22
SC 13G
CITADEL ADVISORS LLC
23 Apr 21
SC 13D
Bpifrance Participations SA
23 Apr 21
SC 13G
ORBIMED ADVISORS LLC
20 Apr 21
SC 13D
Versant Venture Capital V, L.P.
20 Apr 21
SC 13G
Novo Holdings A/S
14 Apr 21